Indication
Cholestatic Liver Disease
4 clinical trials
3 products
Clinical trial
MRX-800: A Long-Term Safety Study of Maralixibat, an Apical Sodium Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat StudyStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Product
MaralixibatClinical trial
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille SyndromeStatus: Active (not recruiting), Estimated PCD: 2023-08-22
Clinical trial
A Phase 1, Open-Label Extension Groups Study in Subjects Having Hepatic Impairment With Cirrhosis Due to Cholestatic Liver DiseaseStatus: Recruiting, Estimated PCD: 2024-03-01
Product
Saroglitazar MagnesiumClinical trial
The Role of Probiotics in Chronic Cholestasis to Prevent Gastrointestinal Diseases in Pediatric Patients in Cipto Mangunkusumo HospitalStatus: Active (not recruiting), Estimated PCD: 2023-12-01
Product
probiotics